Unique ID issued by UMIN | UMIN000052397 |
---|---|
Receipt number | R000059653 |
Scientific Title | Efficacy and safety of a novel needle-type knife with through the needle fluid injection compared to a conventional needle-type knife for colorectal ESD |
Date of disclosure of the study information | 2023/10/04 |
Last modified on | 2025/04/04 11:09:31 |
Efficacy and safety of a novel needle-type knife with through the needle fluid injection compared to a conventional needle-type knife for colorectal ESD
Efficacy and Safety of the Tech Knife for Colorectal ESD
Efficacy and safety of a novel needle-type knife with through the needle fluid injection compared to a conventional needle-type knife for colorectal ESD
Efficacy and Safety of the Tech Knife for Colorectal ESD
Japan |
Colorectal tumor
Gastroenterology |
Malignancy
NO
To evaluate the efficacy and safety of the tech knife in colorectal ESD compared with a conventional needle-type knife, dual knife J.
Safety
Resection time
Resection speed
Number of times the device is inserted and removed
Total local injection volume (volume of sodium hyaluronate solution and saline combined)
Intraoperative perforation rate
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Device,equipment |
Group A: Tech knife group
Group A performs ESD using a Tech knife.
Group B: Dual knife J group
Group B performs ESD using a Dual knife.
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients undergoing endoscopic submucosal dissection (ESD) for colorectal tumor.
2) Patients have been diagnosed with colorectal adenoma or early stage colorectal cancer (including suspected cancer) with suspected submucosal slight invasion larger than 20 mm.
3) Patients are more than 20 years old at the time of registration.
2) PS (ECOG) is either 0 or 1.
3) Written consent has been obtained after sufficient informed consent for participation in this study.
1) Giant lesions with a tumor diameter of 50 mm or more or more than 3/4 circumference
2) Extension into or proximity to the appendiceal orifice or diverticulum, requiring ESD treatment of the orifice or diverticular area
3) Local recurrence after endoscopic resection or postoperative anastomotic lesions
4) Colorectal cancer with inflammatory bowel disease
5) Familial adenomatous colorectal adenomatosis
6) Patients with infectious diseases requiring systemic treatment
7) Patients with serious comorbidities that make it difficult for them to participate in this study
8) Women of childbearing potential, pregnant, or lactating women
9) Positive COVID19 antigen test or PCR test, etc. in advance. No symptoms are required.
10) Other cases in which participation in this study is deemed inappropriate by the physician in charge
270
1st name | Ken |
Middle name | |
Last name | Ohata |
NTT medical center Tokyo
Department of Gastrointestinal Endoscopy
141-0022
5 Chome-9-22 Higashigotanda, Shinagawa City, Tokyo
03-3448-6111
ken.ohata1974@gmail.com
1st name | Yuki |
Middle name | |
Last name | Kano |
NTT medical center Tokyo
Department of Gastrointestinal Endoscopy
141-0022
5 Chome-9-22 Higashigotanda, Shinagawa City, Tokyo
03-3448-6111
snowsmile19870628@gmail.com
NTT medical center Tokyo
Yuki Kano
None
Other
NTT medical center Tokyo Ethics Committee
5 Chome-9-22 Higashigotanda, Shinagawa City, Tokyo
0334486111
snowsmile19870628@gmail.com
NO
NTT東日本関東病院(東京都)
2023 | Year | 10 | Month | 04 | Day |
Unpublished
Open public recruiting
2023 | Year | 06 | Month | 14 | Day |
2023 | Year | 09 | Month | 01 | Day |
2023 | Year | 10 | Month | 16 | Day |
2025 | Year | 06 | Month | 30 | Day |
2025 | Year | 06 | Month | 30 | Day |
2025 | Year | 06 | Month | 30 | Day |
2025 | Year | 06 | Month | 30 | Day |
2023 | Year | 10 | Month | 04 | Day |
2025 | Year | 04 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059653